Tscan Therapeutics, Inc. · NASDAQ:TCRX
EcoR1 Capital, LLC's stake in Tscan Therapeutics, Inc. fell to 1.30% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
EcoR1 Capital, LLC's stake in Tscan Therapeutics, Inc. fell to 1.30%, 662,833 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 1.30%
- Shares
- 662,833
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| EcoR1 Capital, LLC | 1.30% | 662,833 |
| Oleg Nodelman | 1.30% | 662,833 |
| EcoR1 Capital Fund Qualified, L.P. | 1.20% | 623,967 |
Source
Related
- Tscan Therapeutics, Inc.
- EcoR1 Capital, LLC
- Tscan Therapeutics, Inc. shareholders
- Form 4 · MacBeath Gavin · Oct 2, 2026
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G · Readout Capital, LP · Sep 25, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026